Response Announces Second Quarter Results
Tue, 10 Aug 2010 11:30:00 UT
Response Biomedical Corporation today announced financial results for the second quarter and six months ended June 30, 2010. Revenue from product sales for the three month period ended June... More...
  Response Closes $8 Million Private Placement
Wed, 28 Jul 2010 21:14:00 UT
Response Biomedical Corporation (the “Company”) announced today that it has closed its previously announced private placement of common shares for gross proceeds of approximately $8 million... More...
  Response Shareholders Approve $8 Million Private Placement
Tue, 27 Jul 2010 16:24:00 UT
Response Biomedical Corporation (the “Company”) announced that at the Company’s Special General Shareholders’ Meeting held today in Vancouver, shareholders approved the private placement of... More...
  Response Announces Subscription Agreement for $8 Million Private Placement
Mon, 28 Jun 2010 12:00:00 UT
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBF) announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated... More...
  Response to Present at Noble Financial Sixth Annual Equity Conference – ONTRACK 2010
Thu, 3 Jun 2010 09:00:00 UT
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBFD) today announced that S. Wayne Kay, Chief Executive Officer, will make a presentation regarding the business strategy of the Company a... More...
  Response Announces Share Consolidation
Wed, 26 May 2010 21:08:00 UT
Response Biomedical Corporation today announced that the Company has effected a share consolidation in accordance with the authority granted by shareholders at the Company’s annual general ... More...
  Response Granted Class 3 Medical Device License by Health Canada to Market RSV Assay i...
Mon, 17 May 2010 12:00:00 UT
Response Biomedical Corporation today announced that it has been granted a Class 3 (near patient/point-of-care) Medical Device license by Health Canada to market its RAMP® Respiratory Syncy... More...
  Response Announces First Quarter Results
Tue, 4 May 2010 12:00:00 UT
Response Biomedical Corporation today announced financial results for the first quarter ended March 31, 2010. Total revenues for the three month period ended March 31, 2010 decreased 43% to... More...
  Response to Present at Roth 22nd Annual OC Growth Stock Conference
Tue, 16 Mar 2010 12:00:00 UT
Response Biomedical Corporation reported that S. Wayne Kay, Chief Executive Officer, will present at the Roth 22nd Annual OC Growth Stock Conference on March 16, 2010. The Roth conference i... More...
  Response Announces 2009 Financial Results
Thu, 11 Mar 2010 12:00:00 UT
Response Biomedical Corporation reported that it recorded total revenues of $9,946,269, an increase of 69% compared to $5,876,337 in 2008. Clinical products revenue for the year ended Decem... More...